Jörg Pabel

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Venues

Journal of medicinal chemistry

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Sabine Willems, Romy Busch, Felix Nawa, Marco Ballarotto, Felix F Lillich, Till Kasch, Úrsula López-García, Julian A Marschner, Lorena A Rüger, Beatrice Renelt, Julia Ohrndorf, Silvia Arifi, Daniel Zaienne, Ewgenij Proschak, Jörg Pabel, Daniel Merk
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism. Journal of medicinal chemistry 67 (15) (2024)
Sabine Willems, Romy Busch, Felix Nawa, Marco Ballarotto, Felix F Lillich, Till Kasch, Úrsula López-García, Julian A Marschner, Lorena A Rüger, Beatrice Renelt, Julia Ohrndorf, Silvia Arifi, Daniel Zaienne, Ewgenij Proschak, Jörg Pabel, Daniel Merk
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism. Journal of medicinal chemistry 67 (15) (2024)
Laura Isigkeit, Tim Hörmann, Espen Schallmayer, Katharina Scholz, Felix F Lillich, Johanna H M Ehrler, Benedikt Hufnagel, Jasmin Büchner, Julian A Marschner, Jörg Pabel, Ewgenij Proschak, Daniel Merk
Automated design of multi-target ligands by generative deep learning. Nature communications 15 (1) (2024)
Felix Nawa, Minh Sai, Jan Vietor, Roman Schwarzenbach, Anesa Bitić, Sina Wolff, Niklas Ildefeld, Jörg Pabel, Thomas Wein, Julian A Marschner, Jan Heering, Daniel Merk
Tuning RXR Modulators for PGC1α Recruitment. Journal of medicinal chemistry (2024)
Sabine Willems, Romy Busch, Felix Nawa, Marco Ballarotto, Felix F Lillich, Till Kasch, Úrsula López-García, Julian A Marschner, Lorena A Rüger, Beatrice Renelt, Julia Ohrndorf, Silvia Arifi, Daniel Zaienne, Ewgenij Proschak, Jörg Pabel, Daniel Merk
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism. Journal of medicinal chemistry (2024)
Jan Vietor, Christian Gege, Tanja Stiller, Romy Busch, Espen Schallmayer, Hella Kohlhof, Georg Höfner, Jörg Pabel, Julian A Marschner, Daniel Merk
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications. Journal of medicinal chemistry 66 (9) (2023)
Jan Vietor, Christian Gege, Tanja Stiller, Romy Busch, Espen Schallmayer, Hella Kohlhof, Georg Höfner, Jörg Pabel, Julian A Marschner, Daniel Merk
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications. Journal of medicinal chemistry 66 (9) (2023)
Jan Vietor, Christian Gege, Tanja Stiller, Romy Busch, Espen Schallmayer, Hella Kohlhof, Georg Höfner, Jörg Pabel, Julian A Marschner, Daniel Merk
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications. Journal of medicinal chemistry (2023)
Jan Vietor, Christian Gege, Tanja Stiller, Romy Busch, Espen Schallmayer, Hella Kohlhof, Georg Höfner, Jörg Pabel, Julian A Marschner, Daniel Merk
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications. Journal of medicinal chemistry 66 (9) (2023)
Minh Sai, Jan Vietor, Moritz Kornmayer, Markus Egner, Úrsula López-García, Georg Höfner, Jörg Pabel, Julian A Marschner, Thomas Wein, Daniel Merk
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand Dihydroxyindole. Journal of medicinal chemistry (2023)
Gustave Adouvi, Felix Nawa, Marco Ballarotto, Lorena Andrea Rüger, Loris Knümann, Till Kasch, Silvia Arifi, Manfred Schubert-Zsilavecz, Sabine Willems, Julian A Marschner, Jörg Pabel, Daniel Merk
Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency. Journal of medicinal chemistry (2023)
Jan Vietor, Christian Gege, Tanja Stiller, Romy Busch, Espen Schallmayer, Hella Kohlhof, Georg Höfner, Jörg Pabel, Julian A Marschner, Daniel Merk
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications. Journal of medicinal chemistry 66 (9) (2023)
Jan Vietor, Christian Gege, Tanja Stiller, Romy Busch, Espen Schallmayer, Hella Kohlhof, Georg Höfner, Jörg Pabel, Julian A Marschner, Daniel Merk
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications. Journal of medicinal chemistry 66 (9) (2023)

Jörg Pabel.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jörg Pabel